Novartis Venture Fund Parent: Novartis
Novartis Venture Fund (NVF) is a stage-agnostic venture arm of Novartis, engaging in investments from seed- to later-stage life sciences companies across Biotechnology/Biopharma, Medical Devices, and Diagnostics. Its primary focus is on the development of novel therapeutics and platforms, with a preference to either lead or co-lead an investment and play an active role on company boards. NVF's portfolio companies span North America, Europe, Israel, and Asia/Pacific.
Founded 1996
Employees 10+
Primary contact
Novartis International AG, P.O. Box
4002 Basel
Switzerland
Novartis International AG, P.O. Box
4002 Basel
Switzerland
Links
http://www.nvfund.com/
http://www.nvfund.com/
Key people 🧑🤝🧑
- Dr. Anja König - Global Head
- Dr. Laura Brass - Managing Director in Cambridge, MA
- Bart Dzikowski - Managing Director & Head of Transactions & Legal
- Dr. Florian Muellershausen - Managing Director in Basel, Switzerland
- Dr. Aaron Nelson - Managing Director in Cambridge, MA
- Dr. Nandita Shangari - Managing Director in Cambridge, MA
- Dr. Beat Steffen - Managing Director in Basel, Switzerland
- Dr. Marianne Uteng - Principal
Investments 💸
Biotech company exploiting Protein Splicing to develop the next generation of gene therapies
📍 Barcelona, Spain
Last update:
November 1, 2022
Disclaimer: The content on this page is not an investment advice and does not constitute any offer or solicitation to offer or recommendation of any investment product. It is for general purposes only and does not take into account your individual needs, investment objectives and specific financial circumstances.